Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)‐exposed and TDF‐unexposed HIV‐infected out‐patients receiving highly active antiretroviral therapy

Objectives Cases of hypophosphataemia (often coincident with renal dysfunction) have been reported in HIV‐infected patients taking tenofovir disoproxil fumarate (TDF), but randomized placebo‐controlled trials of HIV‐infected persons with normal baseline renal function have found a comparable inciden...

Ausführliche Beschreibung